COVID-19 Drug Headed for Phase III Clinical Trial

Pulmonem Inc., a Canadian biotech start-up, is pleased to announce Health Canada approval of the Phase III Randomized Clinical Trial of an oral medication developed by the company as an early treatment to reduce or even prevent the development of severe pulmonary...

Heroes behind the scenes: the MUHC Microbiology Lab

Throughout the COVID-19 pandemic, we have been hearing many stories of physicians administering life saving treatment or nurses caring for patients in the ICU. The stories we seldom hear are those of the people working to address this health crisis behind the scenes....

MI4 Addressing the Threat of Coronavirus

The threat of coronavirus Just days into 2020, researchers in Wuhan, China announced that a spike in pneumonia cases was, in fact, a new strain of coronavirus. Within weeks, cases of this new disease were being reported worldwide. Mere months later, on March 11, 2020,...

Rare Disease Day: cracking medical mysteries

Dr. Donald Vinh is often referred to as the Research Institute of the McGill University Health Centre (RI-MUHC)’s Dr. House, as he and his team work to crack some of the country’s most complex medical cases. It is estimated that there are more than 7,000 rare diseases...